KRSA
Korsana Biosciences, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$34.99
+3.77%Margins
Gross margin
61.6%
EBITDA margin
-353.0%
EBIT margin
-359.2%
Net margin
-353.0%
FCF margin
-234.3%
-131.8%
Return on equity
-96.8%
Return on assets
-134.1%
Return on invested capital
0.25x
Asset turnover
-$4.5M
Cash from operations
$0.02
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026